The Role of Wnt Signalling in Angiogenesis

Overview

Journal Clin Biochem Rev

Specialty Biochemistry

Date 2018 Jan 16

PMID 29332977

Citations 92

Authors

Jun Jun Olsen

Sebastian Other-Gee Pohl

Abhijeet Deshmukh

Malini Visweswaran

Natalie C Ward

Frank Arfuso

Mark Agostino

Arun Dharmarajan

Affiliations

Soon will be listed here.

Abstract

Angiogenesis is a normal biological process wherein new blood vessels form from the growth of pre-existing blood vessels. Preventing angiogenesis in solid tumours by targeting pro-angiogenic factors including vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), basic fibroblast growth factor (bFGF), hepatocyte growth factor, and platelet-derived growth factor (PDGF) is currently under investigation for cancer treatment. Concurrently targeting the cell signalling pathways involved in the transcriptional and post-translational regulation of these factors may provide positive therapeutic results. One such pathway is the Wnt signalling pathway. Wnt was first discovered in mice infected with mouse mammary tumour virus, and has been crucial in improving our understanding of oncogenesis and development. In this review, we summarise molecular and cellular aspects of the importance of Wnt signalling to angiogenesis, including β-catenin-dependent mechanisms of angiogenic promotion, as well as the study of Wnt antagonists, such as the secreted frizzled-related protein family (SFRPs) which have been shown to inhibit angiogenesis. The growing understanding of the underlying complexity of the biochemical pathways mediating angiogenesis is critical to the identification of new molecular targets for therapeutic applications.

Citing Articles

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma.

Ding Y, Chen Q Front Oncol. 2025; 14:1456959.

PMID: 40028002 PMC: 11867957. DOI: 10.3389/fonc.2024.1456959.

Endothelial activating transcription factor 3 promotes angiogenesis and vascular repair in the mouse retina.

Ueda C, Sakimoto S, Yoshihara M, Takigawa T, Shiraki A, Yamaguchi K iScience. 2025; 28(1):111516.

PMID: 39790557 PMC: 11714383. DOI: 10.1016/j.isci.2024.111516.

Functional and Biological Characterization of the LGR5Δ5 Splice Variant in HEK293T Cells.

Kappler M, Thielemann L, Glass M, Caggegi L, Guttler A, Pyko J Int J Mol Sci. 2025; 25(24.

PMID: 39769183 PMC: 11678308. DOI: 10.3390/ijms252413417.

Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemia.

Hwang B, Jeon M, Jang J, Cho Y, Lee D, Min J MAbs. 2024; 16(1):2435478.

PMID: 39607038 PMC: 11610559. DOI: 10.1080/19420862.2024.2435478.

Sonic hedgehog signalling pathway in CNS tumours: its role and therapeutic implications.

Wireko A, Ben-Jaafar A, Kong J, Mannan K, Sanker V, Rosenke S Mol Brain. 2024; 17(1):83.

PMID: 39568072 PMC: 11580395. DOI: 10.1186/s13041-024-01155-w.

References

Lu F, Zhao X, Wu J, Cui Y, Mao Y, Chen K . MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis. Int J Cardiol. 2012; 167(6):2524-32. DOI: 10.1016/j.ijcard.2012.06.052. View

Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H . Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway. Stem Cells Transl Med. 2015; 4(5):513-22. PMC: 4414225. DOI: 10.5966/sctm.2014-0267. View

John A, Tuszynski G . The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001; 7(1):14-23. DOI: 10.1007/BF03032599. View

Basu S, Haase G, Ben-Zeev A . Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res. 2016; 5. PMC: 4841194. DOI: 10.12688/f1000research.7579.1. View

Moon R, Kohn A, De Ferrari G, Kaykas A . WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5(9):691-701. DOI: 10.1038/nrg1427. View

Jackson H, Defamie V, Waterhouse P, Khokha R . TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer. 2016; 17(1):38-53. DOI: 10.1038/nrc.2016.115. View

Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

Muley A, Majumder S, Kolluru G, Parkinson S, Viola H, Hool L . Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010; 176(3):1505-16. PMC: 2832169. DOI: 10.2353/ajpath.2010.090465. View

Dijksterhuis J, Baljinnyam B, Stanger K, Sercan H, Ji Y, Andres O . Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs. J Biol Chem. 2015; 290(11):6789-98. PMC: 4358105. DOI: 10.1074/jbc.M114.612648. View

10.

Hoogeboom D, Essers M, Polderman P, Voets E, Smits L, Burgering B . Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J Biol Chem. 2008; 283(14):9224-30. DOI: 10.1074/jbc.M706638200. View

11.

Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J . Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Oncotarget. 2016; 7(5):5754-68. PMC: 4868719. DOI: 10.18632/oncotarget.6805. View

12.

Yan D, Wiesmann M, Rohan M, Chan V, Jefferson A, Guo L . Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A. 2001; 98(26):14973-8. PMC: 64968. DOI: 10.1073/pnas.261574498. View

13.

Goodwin A, DAmore P . Wnt signaling in the vasculature. Angiogenesis. 2003; 5(1-2):1-9. DOI: 10.1023/a:1021563510866. View

14.

Janda C, Waghray D, Levin A, Thomas C, Garcia K . Structural basis of Wnt recognition by Frizzled. Science. 2012; 337(6090):59-64. PMC: 3577348. DOI: 10.1126/science.1222879. View

15.

Scholz B, Korn C, Wojtarowicz J, Mogler C, Augustin I, Boutros M . Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling. Dev Cell. 2016; 36(1):79-93. DOI: 10.1016/j.devcel.2015.12.015. View

16.

Seo D, Li H, Guedez L, Wingfield P, Diaz T, Salloum R . TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003; 114(2):171-80. DOI: 10.1016/s0092-8674(03)00551-8. View

17.

Brandes A, Bartolotti M, Tosoni A, Poggi R, Franceschi E . Practical management of bevacizumab-related toxicities in glioblastoma. Oncologist. 2015; 20(2):166-75. PMC: 4319633. DOI: 10.1634/theoncologist.2014-0330. View

18.

Perren T, Swart A, Pfisterer J, Ledermann J, Pujade-Lauraine E, Kristensen G . A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011; 365(26):2484-96. DOI: 10.1056/NEJMoa1103799. View

19.

Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1(1):27-31. DOI: 10.1038/nm0195-27. View

20.

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View